This inventor holds 1 USPTO granted patent. Top assignee: Zeneca Limited. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Paul Robert Owen: Innovator in Squalene Synthase Inhibition
Introduction
Paul Robert Owen is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of biochemistry, particularly in the development of pharmaceutical compounds. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Owen holds a patent for "Quinclidine derivatives as squalene synthase inhibitors." This invention represents a breakthrough in the search for effective treatments targeting squalene synthase, an enzyme involved in cholesterol biosynthesis. His patent is a testament to his dedication to advancing medical science.
Career Highlights
Paul Robert Owen is associated with Zeneca Limited, a prominent company in the pharmaceutical industry. His role at Zeneca has allowed him to collaborate with leading experts and contribute to groundbreaking research. His work has been instrumental in developing new therapeutic strategies.
Collaborations
Owen has worked alongside esteemed colleagues, including Keith Blakeney Mallion and George R Brown. These collaborations have fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.
Conclusion
Paul Robert Owen's contributions to the field of biochemistry and his innovative patent highlight his role as a key figure in pharmaceutical research. His work continues to inspire future innovations in health and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile